Detalhe da pesquisa
1.
Predicting liver-related events in NAFLD: A predictive model.
Hepatology
; 78(4): 1240-1251, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994693
2.
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis.
Hepatology
; 73(6): 2238-2250, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978796
3.
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis.
Clin Gastroenterol Hepatol
; 19(1): 136-145.e6, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32389886
4.
Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
Hepatology
; 79(6): E153-E154, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349675
5.
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Gastroenterology
; 155(2): 443-457.e17, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29733831
6.
Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand.
Liver Transpl
; 25(1): 25-34, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30609187
8.
Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.
Hepatology
; 63(6): 1875-87, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26849287
9.
Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH.
Liver Int
; 37(12): 1887-1896, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28544769
10.
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
Gastroenterology
; 149(2): 367-78.e5; quiz e14-5, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865049
11.
The Natural Course of Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci
; 17(5)2016 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27213358
12.
Risk factors associated with the development of hyperamylasemia and post-ERCP pancreatitis in the Cuban National Institute.
Rev Gastroenterol Peru
; 34(2): 127-32, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25028902
13.
[Nonalcoholic fatty liver disease. A current perspective]. / Enfermedad hepática por depósitos grasos. Una perspectiva actual.
Acta Gastroenterol Latinoam
; 43(3): 254-60, 2013 Sep.
Artigo
em Espanhol
| MEDLINE | ID: mdl-24303694
15.
Editorial: targeting liver biopsy in NAFLD - the need to expand non-invasive tools.
Aliment Pharmacol Ther
; 55(1): 126-127, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907574
16.
Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis.
Dig Liver Dis
; 48(3): 283-90, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26797261
17.
Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial.
BMJ Open
; 1(2): e000140, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22021873
18.
Validación de técnica inmunoquímica para detección de sangre oculta en heces / Validation of an immunochemical technique for the detection of fecal occult blood
Rev. cuba. invest. bioméd
; 33(1): 19-33, ene.-mar. 2014. tab
Artigo
em Espanhol
| LILACS, CUMED | ID: lil-722955
19.
Risk factors associated with the development of hyperamylasemia and post-ERCP pancreatitis in the Cuban National Institute / Factores de riesgo con el desarrollo de la hiperamilasemia y pancreatitis post PCRE en el Cuban National Institute
Rev. gastroenterol. Perú
; 34(2): 127-132, abr. 2014. ilus, tab
Artigo
em Espanhol
| LILACS, LIPECS | ID: lil-717368
20.
Modelos pronósticos para la cirrosis hepática / Prognostic models for hepatic cirrhosis
Rev. cuba. med
; 50(2): 190-201, abr.-jun. 2011.
Artigo
em Espanhol
| LILACS | ID: lil-615424